The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Evolving epidemiology of hepatitis C virus
Open accessAbstract
More than 20 years after the discovery of the hepatitis C virus (HCV), it is now well established that HCV is of global importance affecting all countries, leading to a major global health problem that requires widespread active interventions for its prevention and control. Chronic hepatitis C was linked to the development of cirrhosis and hepatocellular carcinoma in many areas of the world. Current epidemiological assessments have identified complex patterns with highly variable local prevalence rates between countries and within countries. HCV infection patterns have not significantly changed in most parts of the world since 1997, when first analyzed, partly due to the lack of new and more accurate data. The assessment of the national HCV prevalence and transmission modes should be completed to enable national authorities to prioritize preventive measures and to make the most appropriate use of available resources. The 'patchy' epidemiological situation in some areas will continue to complicate the task of the establishment of global, regional and national base line data. The present assessment finds a global prevalence of 2.35%, affecting 160 million chronically infected individuals. There is an urgent need for more accurate Information on the costs and burden of HCV to society. Twenty-one year after the discovery of HCV, the assessment is far from being complete and little progress has been made in the past 10 years in many countries. In some countries significant increases have been reported and this may also apply to countries were insufficient data exist. A safe and efficient vaccine against HCV is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Epidemiology of hepatitis C virus infection
Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,339
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Self-citationAlter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
A proposed system for the nomenclature of hepatitis C viral genotypes
Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., Brouwer, J. T., Chan, S.-W., Chayama, K., Chen, D.-S., et al. (1994) · Hepatology · doi:10.1002/hep.1840190538 · Cited by 1,023
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 904
Prüss‐Üstün, A., Rapiti, E., & Hutin, Y. (2005) · American Journal of Industrial Medicine · doi:10.1002/ajim.20230 · Cited by 878
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Aach, R. D., Stevens, C. E., Hollinger, F. B., Mosley, J. W., Peterson, D. A., Taylor, P. E., Johnson, R. G., Barbosa, L. H., & Nemo, G. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251901 · Cited by 523
Viral Hepatitis and Liver Disease
Gupta, S., & Ott, M. (1998) · Principles of Molecular Medicine · doi:10.1007/978-1-59259-726-0_43 · Cited by 518
McOmish, F., Yap, P. L., Dow, B. C., Follett, E. A., Seed, C., Keller, A. J., Cobain, T. J., Krusius, T., Kolho, E., & Naukkarinen, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.884-892.1994 · Cited by 509
Global Burden of Disease (GBD) for Hepatitis C
The Global Burden of Hepatitis C Working Group (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258669 · Cited by 488
A comparison of fibrosis progression in chronic liver diseases
Poynard, T., Mathurin, P., Lai, C.-L., Guyader, D., Poupon, R., Tainturier, M.-H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00413-0 · Cited by 474
Global surveillance and control of hepatitis C
Lavanchy, D., Purcell, R. H., Hollinger, F. B., et al. (1999) · UCL Discovery (University College London) · Cited by 433
Self-citationDavidson, F., Simmonds, P., Ferguson, J. C., Jarvis, L. M., Dow, B. C., Follett, E. A. C., Seed, C. R. G., Krusius, T., Lin, C., Medgyesi, G. A., et al. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-5-1197 · Cited by 409
Lavanchy, D. (1999) · PubMed · Cited by 374
Self-citationHepatitis C--global prevalence (update).
(1999) · PubMed · Cited by 270
EASL International Consensus Conference on Hepatitis C
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80366-3 · Cited by 268
Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L., Simmonds, P., & The International HCV Collaborative Study Group (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-10-2493 · Cited by 268
Syringe Exchange and Risk of Infection with Hepatitis B and C Viruses
Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., & Alexander, E. R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009792 · Cited by 256
Mühlberger, N., Schwarzer, R., Lettmeier, B., Sroczynski, G., Zeuzem, S., & Siebert, U. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-34 · Cited by 239
van Beek, I., Dwyer, R., Dore, G. J., Luo, K., & Kaldor, J. M. (1998) · BMJ · doi:10.1136/bmj.317.7156.433 · Cited by 234
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt
Miller, F. D., & Abu-Raddad, L. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008877107 · Cited by 203
Epidemiology of hepatitis C virus infection in Australia
Dore, G. J., Law, M., MacDonald, M., & Kaldor, J. M. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00116-6 · Cited by 193
Epidemiology of hepatitis C virus infection among injecting drug users in Australia.
Crofts, N., Jolley, D., Kaldor, J., van Beek, I., & Wodak, A. (1997) · Journal of Epidemiology and Community Health · doi:10.1136/jech.51.6.692 · Cited by 169
Xia, X., Luo, J., Bai, J., & Yu, R. (2008) · Public Health · doi:10.1016/j.puhe.2008.01.014 · Cited by 158
Deuffic‐Burban, S., Poynard, T., Sulkowski, M., & Wong, J. B. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00785.x · Cited by 151
The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.
Bisceglie, A. M. D., Order, S. E., Klein, J., Waggoner, J. G., Sjögren, M. H., Kuo, G. C., Houghton, M., Choo, Q. L., & Hoofnagle, J. H. (1991) · PubMed · Cited by 150
EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus Statement
(1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80367-5 · Cited by 140
Mukhopadhya, A. (2008) · Journal of Biosciences · doi:10.1007/s12038-008-0065-0 · Cited by 135
Jeannel, D., Fretz, C., Traoré, Y., Kohdjo, N., Bigot, A. K., Gamy, É. P., Jourdan, G., Kourouma, K., Maertens, G. G., Fumoux, F., et al. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199806)55:2<92::aid-jmv2>3.0.co;2-i · Cited by 134
NON-A, NON-B POST-TRANSFUSION HEPATITIS
Dienstag, J. L., Purcell, R., Alter, H. J., Feinstone, S., Wong, D., & Holland, P. V. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91996-1 · Cited by 128
Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003
Tanaka, H., Imai, Y., Hiramatsu, N., Ito, Y., Imanaka, K., Oshita, M., Hijioka, T., Katayama, K., Yabuuchi, I., Yoshihara, H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00004 · Cited by 127
Hepatitis C antibody prevalence in blood donors in different governorates in Egypt
Arthur, R. R., Hassan, N. F., Abdallah, M. Y., El-Sharkawy, M. S., Saad, M. D., Hackbart, B. G., & Imam, I. Z. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90070-5 · Cited by 126
Broers, B., Junet, C., Bourquin, M., Déglon, J., Perrin, L. H., & Hirschel, B. J. (1998) · AIDS · doi:10.1097/00002030-199815000-00018 · Cited by 121
Hutchinson, S. J., Bird, S. M., & Goldberg, D. J. (2005) · Hepatology · doi:10.1002/hep.20836 · Cited by 120
Systematic review of HIV and HCV infection among drug users in China
Bao, Y.-P., & Zm, L. (2009) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008362 · Cited by 118
Darwish, M. A., Faris, R., Clemens, J. D., Rao, M. R., & Edelman, R. (1996) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.54.554 · Cited by 116
Sagnelli, E., Stroffolini, T., Mele, A., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20313 · Cited by 111
Buti, M., Miguel, R. S., Brosa, M., Hita, J. M. C., Medina, M., Casado, M. Á., Fosbrook, L., & Esteban, R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.031 · Cited by 108
Prediction of Hepatitis C Burden in Canada
Zou, S., Tepper, M., & ElSaadany, S. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/642707 · Cited by 99
Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa
Markov, P. V., Pépin, J., Frost, E. H., Deslandes, S., Labbé, A., & Pybus, O. G. (2009) · Journal of General Virology · doi:10.1099/vir.0.011569-0 · Cited by 98
Perz, J. F., Thompson, N. D., Schaefer, M. K., & Patel, P. R. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.11.004 · Cited by 85
High prevalence of hepatitis C virus among urban and rural population groups in Egypt
Gohary, A. E., Hassan, A., Nooman, Z. M., Lavanchy, D., Mayerat, C., Ayat, A., Fawaz, N., Gobran, F., Ahmed, M. A. B. H. A., Kawano, F., et al. (1995) · Acta Tropica · doi:10.1016/0001-706x(95)00075-p · Cited by 83
Self-citationGlobal Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group
Hutin, Y. J., Kitler, M. E., Dore, G. J., Armstrong, G. L., Dusheiko, G. M., Grob, P. J., Kew, M. C., Marcellin, P., Seeff, L. B., Beutels, P., et al. (2004) · Cited by 78
Self-citationSeroepidemiological survey of hepatitis B and C virus infections in Ghanaian children
Martinson, F. E. A., Weigle, K. A., Mushahwar, I. K., Weber, D. J., Royce, R. A., & Lemon, S. M. (1996) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199603)48:3<278::aid-jmv11>3.0.co;2-9 · Cited by 69
Epidemiology of Hepatocellular Carcinoma in Japan and Korea
Kim, S. R., Kudo, M., Hino, O., Han, K., Chung, Y. H., & Lee, H.-S. (2008) · Oncology · doi:10.1159/000173419 · Cited by 67
The burden of hepatitis C in England
Sweeting, M. J., Angelis, D. D., Brant, L. J., Harris, H., Mann, A. G., & Ramsay, M. E. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00851.x · Cited by 67
El-Sayed, N., Gomatos, P. J., Rodier, G. R., Wierzba, T. F., Darwish, A., Khashaba, S., & Arthur, R. R. (1996) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.179 · Cited by 66
Stevens, W. S., Kamali, A., Karita, E., Anzala, O. A., Sanders, E. J., Jaoko, W. G., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002043 · Cited by 35
Hepatitis C Virus Infection, Linxian, China1
Zhang, M., Sun, X., Mark, S. D., Chen, W., Wong, L., Dawsey, S. M., Qiao, Y., Fraumeni, J. F., Taylor, P. R., & OʼBrien, T. R. (2005) · Emerging infectious diseases · doi:10.3201/eid1101.031005 · Cited by 31
Hepatitis C: Part I. Routine serologic testing and diagnosis.
Moyer, L. A., Mast, E. E., & Alter, M. J. (1999) · PubMed · Cited by 21
HCV Infection in Egyptian Patients with Acute Hepatitis
Quinti, I., Salman, D. E., Monier, M. K., Hackbart, B. G., Darwish, M. S., El-Zamiaty, D., Paganelli, R., Pandolfi, F., & Arthur, R. R. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018897813268 · Cited by 20
Incidence of hepatitis C virus in Egyptians
El-Ahmady, O., Halim, A., Mansour, O. A., & Salman, T. M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80123-1 · Cited by 20
Modelling the past, current and future HCV burden in France: detailed analysis and perspectives
Deuffic‐Burban, S., Mathurin, P., & Valleron, A. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280208094697 · Cited by 18
The epidemiology and virology of hepatitis C virus genotype 5 in central France
Abergel, A., Ughetto, S., Dubost, S., BONNY, C., Aublet‐Cuvelier, B., Delarocque‐Astagneau, E., Bailly, J., Bommelaer, G., CASANOVA, S., Delteil, J., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03530.x · Cited by 18
Mohamed, M. K., Mm, R., Shoeir, S., & Saber, M. E. (1996) · PubMed · Cited by 16
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Blach, S., Zeuzem, S., Manns, M., Altraif, I., Duberg, A.-S., Muljono, D. H., Waked, I., Alavian, S. M., Lee, M.-H., Negro, F., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30181-9 · Cited by 2,006
Self-citationGlobal epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
Metadata
- Authors
- Lavanchy, D.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 17
- Issue
- 2
- Pages
- 107-115
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1881009043
- Cited by
- 1,318
- References
- 60
- FWCI
- 46.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.